Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
TSMC Stock Flirts with Buy Point as Chip Giant Plans Price Hike Amid AI Demand Artisan Value Fund Reduces Stake in Meta Platforms Valuation and Risk Considerations Consumer Sentiment Plunges to Record Low in May as Iran Conflict Intensifies Inflation Fears American Express National Bank Expands Beyond Credit Cards with HighYield Accounts and NoFee Banking for 2026 Kevin Hassett Hails Record Consumer Spending as Delinquencies Rise and Farm Bankruptcies Surge 46 FLUT Q1 2026 Earnings EPS Slightly Below Estimates Shares Slip agilon health Q1 2026 Earnings Massive EPS Beat Drives Stock Surge MCRB Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Continues RD Focus QH Q4 2021 Earnings Staggering EPS Miss Exposes Deep Operational Challenges USAR Q1 2026 Earnings Narrower Loss Beats Expectations Amid Rare Earth Development Progress Erasca Inc ERAS Slides 315 as Biotech Sector Faces Pressure Key Levels to Watch PMTW Holds Steady Near Resistance PennyMac Mortgage Senior Notes Show Resilience TrustCo Bank TRST Edges Lower Amid Consolidation Near Key Support Levels Red Violet Inc RDVT Holds Near Key Support Amid Modest Pullback AI Drug Discovery for Brain Conditions Draws Investor Interest Crude Oil Prices Tumble as US Signals Potential Iran Nuclear Deal and Strait of Hormuz Reopening Twenty One Capital Stock Rises on Bitcoin Strategy Shift Sustainability of Momentum May Rest on Broader Market Factors Kraken Introduces Bitcoin Vault Offering Yield for Crypto Investors Simpson Manufacturing Q1 2026 Earnings EPS Surges Past Estimates by 1285 Amid Solid Demand UnitedGuardian Inc UG Q2 2025 Earnings Positive EPS Despite Limited Disclosures Shares Edge Higher Janus Living Q1 2026 Earnings EPS Falls Short of Analyst Expectations MSA Safety MSA Q1 2026 Earnings Solid EPS Beat Amid Steady Demand Oragenics Q2 2023 Earnings Narrowing Loss Surprises No Revenue Yet MGTX Q1 2026 Earnings Missed EPS Estimates as PreRevenue Biotech Advances Pipeline